References
- Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA. 1989. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. New England Journal of Medicine 320:559–565.
- Bläuer M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P. 1991. Location of androgen receptor in human skin. Journal of Investigate Dermatology 97:264–268.
- Carmina E, Lobo RA. 2007. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. Journal of Endocrinological Investigation 30:111–116.
- Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ. 1992. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinology 133:467–475.
- Homburg R. 2008. Polycystic ovary syndrome. Clinical Obstetrics and Gynaecology 2:261–274.
- Lloyd J, Crouch NS, Minto CL, Liao LM, Creighton SM. 2005. Female genital appearance: “normality” unfolds. BJOG 112:643–646.
- Oberfield SE, Mondok A, Shahrivar F, Klein JF, Levine LS. 1989. Clitoral size in full-term infants. American Journal of Perinatology 6: 453–454.
- Sane K, Pescovitz OH. 1992. The clitoral index: a determination of clitoral size in normal girls and in girls with abnormal sexual development. Journal of Pediatrics 120:264–266.
- The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81:19–25.
- Verkauf BS, von Thron J, O’Brien WF. 1992. Clitoral size in normal women. Obstetrics and Gynecology 80:41–44.
- Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdóttir H, Gudlaugsdóttir G et al. 2006. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. Journal of Clinical Endocrinology and Metabolism 91:4361–4368.